NCAM1 and myeloid sarcoma: Immune cell profiling of healthy volunteers and untreated patients with clinically isolated syndrome or RR MS revealed a reduction in the frequency of an NK-like population (CD3- CD56+CD8dimCD4−) in MS patients.